OBJETIVO: Discutir el rol del farmacéutico en los Programas de Optimización de Antimicrobianos (PROA’s) para promover desempeños profesionales tendientes contribuir a la contención de su uso irracional en la sociedad.

CONTENIDOS:

1) Resistencia a los antimicrobianos.
2) Situación de los PROA’s a nivel mundial.
3) Descripción de funciones y elementos principales de un PROA
4) Acciones del farmacéutico a nivel hospitalario:
o Características buscadas.
o Entrenamiento especializado.
o Actividades principales.
o Ejemplos de actividades a desarrollar.
5) Acciones del farmacéutico en la comunidad.

EXPOSITOR: Dr. José Pablo Díaz Madriz

Farmacéutico clínico encargado de la optimización de tratamientos y atención directa de pacientes hospitalizados en el Servicio de Farmacia del Hospital Clínica Bíblica (Costa Rica). Graduado de la Universidad de Costa Rica, con posgrado en Farmacología y Gerencia de Medicamentos. Director y fundador del primer Programa de Optimización de Antimicrobianos (PROA) de la región centroamericana. Docente y tutor de internado de la Universidad de Costa Rica y coordinador de la cátedra de Farmacología de la Universidad de Ciencias Médicas. Conferencista internacional. Investigador, con múltiples publicaciones en revistas científicas y congresos internacionales. Participación como farmacéutico en equipos de investigación de estudios clínicos. Asesor en PROA’s para el Ministerio de Salud de Costa Rica y la Organización Panamericana de la Salud. Ganador de beca de viaje para el congreso Mundial de Farmacia y Ciencias Farmacéuticas de la Federación Internacional Farmacéutica celebrado en Seúl (Corea del Sur) en setiembre de 2017.

Learning Objectives:

Provide background information about the International Medication Safety Network (IMSN)
Present the new IMSN Global Targeted Medication Safety Best Practices

-- Describe ongoing safety issues with targeted items
-- Provide IMSN prevention recommendations

Discuss possible barriers and actions that can be implemented to overcome implementation
Present the status of the new IMSN Global Targeted Medication Safety Best Practices in Brazil
Discuss future medication safety improvements

Health for All is a slogan for a movement by the World Health Organization (WHO) to build a better, healthier future for people all over the world. The WHO emphasizes the importance of engaging young people towards achieving Health for All and the Sustainable Development Goals (SDGs), where the priorities are to ensure that no one is left behind. The WHO set the “triple billion” targets which are aimed at achieving the following goals by 2023: ensure that one billion more people will benefit from Universal Health Coverage (UHC), one billion more people will be shielded from health emergencies and one billion more people will live healthy lives at all ages. How can the youth contribute to achieving these goals?

The Young Pharmacists Group of the International Pharmaceutical Federation (FIP YPG) is hosting a webinar in collaboration with the Global Health Workforce Network (GHWN) Youth Hub, the Asian Young Pharmacists Group (AYPG) and the International Pharmaceutical Students' Federation (IPSF). The purpose of this webinar is to explore the challenges faced by students and early career professionals in accessing the health labor market to fill the 18 million health workers shortfall. It will also address issues specific to young pharmacists and their contributions towards the provision of safe and effective medicines in the UHC era. The webinar will provide insights into the WHO triple billion targets with emphasis on the role of students, young pharmacists and pharmaceutical scientists in achieving UHC.

By the end of this webinar, attendees will be able to: (1) Describe the challenges faced by students and early career professionals in the health sector: the importance of investing in youth and the health workforce; (2) Describe the challenges pharmacists face in ensuring safe and effective medicines in the achievement of UHC and explore solutions to address those challenges; (3) Provide an opportunity to reflect on how students and young professionals can contribute to achieving UHC.

Assessing the value of innovative and existing pharmaceutical services provided in primary and/or secondary care represents a major challenge to commissioners and decision makers, given the complex nature of these interventions. The evaluation of these services involves a multitude of dimensions that need to be defined to accurately capture the impact of these services on patient outcomes. Thus, the purpose of this webinar is to share the presenters’ experiences in relation to conducting, reporting and reviewing economic evaluations of pharmaceutical services including technology-enabled services.

Understanding health behavior theories and models can be a valuable tool for pharmacists, both in patient-centered care and population health initiatives. This session aims to describe basic health behavior theory and models, how they are applied in pharmacy practice, and the value to teaching these public health concepts within the pharmacy curriculum.

Learning Objectives:
At the end of the Webinar, participants should be able to:
1. Discuss basic health behavior theory and models
2. Describe ways to apply health behavior theory models to patient care and population health
3. Explain how public health concepts fulfill global pharmacy education standards.

Moderator
Toyin Tofade, MS, PharmD, BCPS, CPCC, FFIP
Dean and Professor, Howard University College of Pharmacy

Speakers
● Hoai-An Truong, PharmD, MPH, Professor and Director of Public Health, University of Maryland Eastern Shore,
● Miranda Law, PharmD, BCPS Assistant Professor, Howard University,
● Robbie Turner, Director of Pharmacy & Member Experience, Royal Pharmaceutical Society

the International Conference on Advances in Pharmaceutical Drug Development, Quality Control and Regulatory Sciences (DDRS 2020) will be organised on Margaret Island, Budapest, 17-19 March, 2020 on the occasion of the 250^th anniversary of the foundation of Semmelweis University in Budapest, Hungary. 

The conference will address new trends in pharmaceutical, regulatory science of biological and non-biological complex drugs (NBCDs) and the challenges for their correct use.

The 25th EAHP Congress 2020 will focus on the latest advances in technologies that will shape the way how pharmaceutical care in hospitals will be delivered in the upcoming decades. Artificial intelligence, mHealth, 3D printing, personalised medicine, all of these will influence our work towards the optimal outcomes for our patients and have the potential to change our workflows profoundly. The Congress will also cover the ongoing challenges in our work, like tackling antimicrobial resistance, delivering seamless care, raising the quality of hospital pharmacy compounding, advances in clinical pharmacy or the role of hospital pharmacists in the multidisciplinary teams in hospital and on the interface with community or outpatient settings, just to name a few.

The scientific programme of the Congress is also tailored to the needs of individual hospital pharmacists and their interest groups as the Congress offers the possibility to choose between many parallel sessions, keynote presentations, workshops and symposia, and plenty of networking opportunities.

This is your opportunity to join experts from around the world in Gothenburg to share experience and ideas and to learn from each other and to discuss the role of new technology in pharmacy.

The 3^rd edition of Phar-East is happening in Singapore from 31 March to 1 April 2020. It is your chance to network with over 1,000 leading experts from across Asia and gain insights about the latest trends in the pharma and biotech industry. The conference will feature 5 premium theatres focusing on immunotherapy, regulatory affairs, Pharma 4.0, market access, biotech investments, clinical trials and an all-new track – Bio Data. Running alongside the conference, will be an all-new innovation and start-up zone, where we will be bringing in more than 80 start-ups in the pharma and biotech industry to share their latest technologies and solutions. Get the latest updates here or download the event brochure here

Join us at Asia’s Pharma & Biotech Festival and be a part of Asia’s fastest growing pharmaceutical and biotech market! Book your tickets now

Come to the 2020 FIP congress in Seville, Spain, where pharmacy practitioners, pharmaceutical scientists and educators from around the world will discuss and help you prepare for these new technologies that will empower our profession.

Previous industrial revolutions liberated humans from reliance on animal power, made mass production possible and brought digital capabilities to billions. This latest industrial revolution is, however, fundamentally different. It is characterised by a range of technologies that are fusing the physical, digital and biological worlds, impacting on all disciplines, economies and industries, and even challenging ideas about what it means to be human.

Digitalisation is already allowing the keeping of structured patient records, facilitating electronic prescribing, dispensing and administration of medicines, automating the handling of medicines in the supply chain, and providing tools for monitoring the efficacy and safety of medicines in use. Further advances will enable pharmacists to interact with patients through the creation of a common platform for accessing data and information in new, more efficient way.